glp-1 anti-obesity GLP-1-based therapies for diabetes, obesity and beyond are glp 1 drugs safe

But I dont think the government sees it that way, and so theyve allowed compounders to copy drugs. In Washington, U.S

Hashimoto's disease, an autoimmune thyroid condition affecting approximately 5% of Americans, often leads to hypothyroidism and challenging weight gain despite standard levothyroxine therapy

For example, even when a person is not hungry, external food cues may still trigger wanting and promote food intake, while liking does not necessarily increase at the same time (28)

Wegovy is effective for weight loss and has been proven so in clinical trials, while Ozempic has not been tested specifically for this purpose, although it may help type 2 diabetics lose some weight

Medication is billed separately

July 1, 2026 , through the Medicare GLP-1 Bridge Program